COVID-19 and multisystem inflammatory syndrome in children and adolescents
Women and Child Health
As severe acute respiratory syndrome coronavirus 2 continues to spread worldwide, there have been increasing reports from Europe, North America, Asia, and Latin America describing children and adolescents with COVID-19-associated multisystem inflammatory conditions. However, the association between multisystem inflammatory syndrome in children and COVID-19 is still unknown. We review the epidemiology, causes, clinical features, and current treatment protocols for multisystem inflammatory syndrome in children and adolescents associated with COVID-19. We also discuss the possible underlying pathophysiological mechanisms for COVID-19-induced inflammatory processes, which can lead to organ damage in paediatric patients who are severely ill. These insights provide evidence for the need to develop a clear case definition and treatment protocol for this new condition and also shed light on future therapeutic interventions and the potential for vaccine development.
Translations: For the French, Chinese, Arabic, Spanish and Russian translations of the abstract see Supplementary Materials section.
The Lancet Infectious Diseases
Morris, S. S.,
Klein, J. D.,
Bhutta, Z. A.
(2020). COVID-19 and multisystem inflammatory syndrome in children and adolescents. The Lancet Infectious Diseases, 20(11), e276-e288.
Available at: https://ecommons.aku.edu/pakistan_fhs_mc_women_childhealth_wc/144